Skip to main content

Table 6 Clinical performance of the Vibrant GPP array with archived clinical specimens

From: Evaluation of the Vibrant DNA microarray for the high-throughput multiplex detection of enteric pathogens in clinical samples

Vibrant GPP panel No: positive samples tested No: negative samples tested Sensitivity % (95% CI) Specificity % (95% CI) PPV % (95% CI) NPV % (95% CI)
Vibrio parahaemolyticus 3 1055 100
(29.2–100)
100
(99.6–100)
100
(29.2–100)
100
(99.6–100)
Vibrio vulnificus 3 1055 100
(29.2–100)
100
(99.6–100)
100
(29.2–100)
100
(99.6–100)
Cryptosporodium spp. 1 1055 100
(2.5–100)
100
(99.6–100)
100
(2.5–100)
100
(99.6–100)
Microsporidium spp. 2 1055 100
(15.8–100)
100
(99.6–100)
100
(15.8–100)
100
(99.6–100)